Anda Trifan

Dr. Anda Trifan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021
Verified
Conference Paper
Open access
ASAymen Al Saadi
Aymen Al Saadi
DADario Alfe
Dario Alfe
YBYadu Babuji
Yadu Babuji
ABAgastya Bhati
Agastya Bhati
BBBen Blaiszik
Ben Blaiszik
JYJunqi Yin
Junqi Yin
The drug discovery process currently employed in the pharmaceutical industry typically requires about 10 years and $2–3 billion to deliver one new drug. This is both too expensive and too slow, especially in emergencies like the COVID-19 pandemic. In silico methodologies need to be improved both to select better lead compounds, so as to improve the efficiency of later stages in the drug discovery protocol, and to identify those lead compounds more quickly. No known methodological approach can deliver this combination of higher quality and speed. Here, we describe an Integrated Modeling PipEline for COVID Cure by Assessing Better LEads (IMPECCABLE) that employs multiple methodological innovations to overcome this fundamental limitation. We also describe the computational framework that we have developed to support these innovations at scale, and characterize the performance of this framework in terms of throughput, peak performance, and scientific results. We show that individual workflow components deliver 100 × to 1000 × improvement over traditional methods, and that the integration of methods, supported by scalable infrastructure, speeds up drug discovery by orders of magnitudes. IMPECCABLE has screened ∼ 1011 ligands and has been used to discover a promising drug candidate. These capabilities have been used by the US DOE National Virtual Biotechnology Laboratory and the EU Centre of Excellence in Computational Biomedicine.

1 May 2022
Verified
Conference Paper
Open access
ABAlexander Brace
Alexander Brace
IYIgor Yakushin
Igor Yakushin
HMHeng Ma
Heng Ma
ATAnda Trifan
Anda Trifan
TMTodd Munson
Todd Munson
SJShantenu Jha
Shantenu Jha
Machine learning (ML)-based steering can improve the performance of ensemble-based simulations by allowing for online selection of more scientifically meaningful computations. We present DeepDriveMD, a framework for ML-driven steering of scientific simulations that we have used to achieve orders-of-magnitude improvements in molecular dynamics (MD) performance via effective coupling of ML and HPC on large parallel computers. We discuss the design of DeepDriveMD and characterize its performance. We demonstrate that DeepDriveMD can achieve between 100-1000× acceleration for protein folding simulations relative to other methods, as measured by the amount of simulated time performed, while covering the same conformational landscape as quantified by the states sampled during a simulation. Experiments are performed on leadership-class platforms on up to 1020 nodes. The results establish DeepDriveMD as a high-performance framework for ML-driven HPC simulation scenarios, that supports diverse MD simulation and ML back-ends, and which enables new scientific insights by improving the length and time scales accessible with current computing capacity.

15 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAbigail Dommer
Abigail Dommer
LCLorenzo Casalino
Lorenzo Casalino
FKFiona Kearns
Fiona Kearns
MRMia Rosenfeld
Mia Rosenfeld
NWNicholas Wauer
Nicholas Wauer
RARommie Amaro
Rommie Amaro
We seek to completely revise current models of airborne transmission of respiratory viruses by providing never-before-seen atomic-level views of the SARS-CoV-2 virus within a respiratory aerosol. Our work dramatically extends the capabilities of multiscale computational microscopy to address the significant gaps that exist in current experimental methods, which are limited in their ability to interrogate aerosols at the atomic/molecular level and thus ob-scure our understanding of airborne transmission. We demonstrate how our integrated data-driven platform provides a new way of exploring the composition, structure, and dynamics of aerosols and aerosolized viruses, while driving simulation method development along several important axes. We present a series of initial scientific discoveries for the SARS-CoV-2 Delta variant, noting that the full scientific impact of this work has yet to be realized. ACM Reference Format: Abigail Dommer 1† , Lorenzo Casalino 1† , Fiona Kearns 1† , Mia Rosenfeld 1 , Nicholas Wauer 1 , Surl-Hee Ahn 1 , John Russo, 2 Sofia Oliveira 3 , Clare Morris 1 , AnthonyBogetti 4 , AndaTrifan 5,6 , Alexander Brace 5,7 , TerraSztain 1,8 , Austin Clyde 5,7 , Heng Ma 5 , Chakra Chennubhotla 4 , Hyungro Lee 9 , Matteo Turilli 9 , Syma Khalid 10 , Teresa Tamayo-Mendoza 11 , Matthew Welborn 11 , Anders Christensen 11 , Daniel G. A. Smith 11 , Zhuoran Qiao 12 , Sai Krishna Sirumalla 11 , Michael O’Connor 11 , Frederick Manby 11 , Anima Anandkumar 12,13 , David Hardy 6 , James Phillips 6 , Abraham Stern 13 , Josh Romero 13 , David Clark 13 , Mitchell Dorrell 14 , Tom Maiden 14 , Lei Huang 15 , John McCalpin 15 , Christo- pherWoods 3 , Alan Gray 13 , MattWilliams 3 , Bryan Barker 16 , HarindaRajapaksha 16 , Richard Pitts 16 , Tom Gibbs 13 , John Stone 6 , Daniel Zuckerman 2 *, Adrian Mulholland 3 *, Thomas MillerIII 11,12 *, ShantenuJha 9 *, Arvind Ramanathan 5 *, Lillian Chong 4 *, Rommie Amaro 1 *. 2021. #COVIDisAirborne: AI-Enabled Multiscale Computational Microscopy ofDeltaSARS-CoV-2 in a Respiratory Aerosol. In Supercomputing ‘21: International Conference for High Perfor-mance Computing, Networking, Storage, and Analysis . ACM, New York, NY, USA, 14 pages. https://doi.org/finalDOI

5 July 2021
Verified
Conference Paper
Open access
HLHyungro Lee
Hyungro Lee
AMAndre Merzky
Andre Merzky
LTLi Tan
Li Tan
MTMikhail Titov
Mikhail Titov
MTMatteo Turilli
Matteo Turilli
SJShantenu Jha
Shantenu Jha
COVID-19 has claimed more than 2.7 × 106 lives and resulted in over 124 × 106 infections. There is an urgent need to identify drugs that can inhibit SARS-CoV-2. We discuss innovations in computational infrastructure and methods that are accelerating and advancing drug design. Specifically, we describe several methods that integrate artificial intelligence and simulation-based approaches, and the design of computational infrastructure to support these methods at scale. We discuss their implementation, characterize their performance, and highlight science advances that these capabilities have enabled.

1 January 2021 in Current Research in Structural Biology
Verified
Journal Article
Open access
JSJanina Sprenger
Janina Sprenger
ATAnda Trifan
Anda Trifan
NPNeal Patel
Neal Patel
AVAshley Vanderbeck
Ashley Vanderbeck
JBJenny Bredfelt
Jenny Bredfelt
SLSara Linse
Sara Linse
Calmodulin (CaM) is a ubiquitous Ca2+ sensing protein that binds to and modulates numerous target proteins and enzymes during cellular signaling processes. A large number of CaM-target complexes have been identified and structurally characterized, revealing a wide diversity of CaM-binding modes. A newly identified target is creatine kinase (CK), a central enzyme in cellular energy homeostasis. This study reports two high-resolution X-ray structures, determined to 1.24 ​Å and 1.43 ​Å resolution, of calmodulin in complex with peptides from human brain and muscle CK, respectively. Both complexes adopt a rare extended binding mode with an observed stoichiometry of 1:2 CaM:peptide, confirmed by isothermal titration calorimetry, suggesting that each CaM domain independently binds one CK peptide in a Ca2+-depended manner. While the overall binding mode is similar between the structures with muscle or brain-type CK peptides, the most significant difference is the opposite binding orientation of the peptides in the N-terminal domain. This may extrapolate into distinct binding modes and regulation of the full-length CK isoforms. The structural insights gained in this study strengthen the link between cellular energy homeostasis and Ca2+-mediated cell signaling and may shed light on ways by which cells can ‘fine tune’ their energy levels to match the spatial and temporal demands.

16 September 2026 in Membranes
Verified
Journal Article
Open access
PDF file
ATAnda Trifan
Anda Trifan
HAHossein Omidi Ardali
Hossein Omidi Ardali
JVJosh Vermaas
Josh Vermaas
TRTill Rudack
Till Rudack
Emad TajkhorshidEmad Tajkhorshid
Emad Tajkhorshid
The small GTPase Ras, a central switch in signal transduction of cell growth, is a crucial element in the development of many forms of cancer. Recent studies have shown that membrane association of Ras is essential to its downstream effector recruitment and signal transduction. Here we investigate the membrane association and interaction of K-Ras4B, the most frequently found Ras isoform in tumor cells, using all-atom molecular dynamics simulations totaling 8.5 μs. We find that the isoform-specific, farnesylated hypervariable region (HVR) of Ras plays an important role in the organization and oligomerization of its globular domain (G-domain) on the surface of the membrane. We show that the overall pose of the Ras G-domain on the membrane can be determined by its HVR. The HVR thus can control downstream effector binding by positioning the G-domain on the membrane in a specific orientation. Furthermore, we observe that the HVR alone already transiently dimerizes in the membrane and recruits negatively charged phosphatidylserine lipids around the K-Ras isoform-specific poly-lysine region. The observed HVR dimerization potentially can initiate the dimerization of the full K-Ras, which is essential for downstream effector signaling via various pathways. These atomistic details behind the molecular mechanism of the HVR provide novel insight into Ras interaction with membrane and its availability for downstream effectors.